By taking over Genentech, Roche has added promising drugs for cancer and other potentially lucrative treatments to its otherwise anaemic research pipeline.

• 通过收购基因泰克，罗氏已经在其贫血症研究方面，增加了抗癌药和其他潜在有利可图的、有前景的治疗方法。